Kestra Medical Technologies (NASDAQ:KMTS) Coverage Initiated at Wells Fargo & Company

Analysts at Wells Fargo & Company initiated coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a research note issued on Monday,Benzinga reports. The brokerage set an “overweight” rating and a $28.00 price target on the stock. Wells Fargo & Company‘s price objective suggests a potential upside of 19.50% from the stock’s current price.

KMTS has been the topic of a number of other research reports. Stifel Nicolaus initiated coverage on Kestra Medical Technologies in a research note on Monday. They issued a “buy” rating and a $28.00 price objective for the company. The Goldman Sachs Group started coverage on shares of Kestra Medical Technologies in a report on Monday. They set a “neutral” rating and a $24.00 price target for the company. Finally, Piper Sandler started coverage on shares of Kestra Medical Technologies in a research report on Monday. They issued an “overweight” rating and a $27.00 target price for the company.

Kestra Medical Technologies Trading Down 2.5 %

Kestra Medical Technologies stock opened at $23.43 on Monday. Kestra Medical Technologies has a 1 year low of $20.00 and a 1 year high of $25.98.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.